BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2955961)

  • 1. Biochemical changes associated with the osmotic fragility of young and mature erythrocytes caused by parathyroid hormone in relation to the uremic syndrome.
    Levi J; Malachi T; Djaldetti M; Bogin E
    Clin Biochem; 1987 Apr; 20(2):121-5. PubMed ID: 2955961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of parathyroid hormone on the fragility and enzyme activities of red blood cells from young and mature rabbits.
    Bogin E; Malachi Z; Djaldeti M; Levi J
    J Clin Chem Clin Biochem; 1987 Feb; 25(2):77-82. PubMed ID: 2952752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of parathyroid hormone on osmotic fragility of human erythrocytes.
    Bogin E; Massry SG; Levi J; Djaldeti M; Bristol G; Smith J
    J Clin Invest; 1982 Apr; 69(4):1017-25. PubMed ID: 6281309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone effect on the fragility of human young and old red blood cells in uremia.
    Malachi T; Bogin E; Gafter U; Levi J
    Nephron; 1986; 42(1):52-7. PubMed ID: 3941750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of parathyroid hormone on antioxidant enzyme activity and lipid peroxidation of erythrocytes in five-sixths nephrectomized rats.
    Chen SM; Young TK
    Nephron; 1996; 73(2):235-42. PubMed ID: 8773350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell osmotic fragility in chronically hemodialyzed patients.
    Wu SG; Jeng FR; Wei SY; Su CZ; Chung TC; Chang WJ; Chang HW
    Nephron; 1998; 78(1):28-32. PubMed ID: 9453400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure.
    Docci D; Turci F; Baldrati L
    Nephron; 1985; 41(3):241-5. PubMed ID: 3840575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of aging on parathyroid hormone-induced enhancement in (Ca2+ + Mg2+)-ATPase activity of rabbit renal basolateral membrane].
    Shiraishi T; Morimoto S; Itoh K; Miyashita Y; Kitano S; Nabata T; Inoue T; Morita R; Taniguchi K; Fukuo K
    Nihon Ronen Igakkai Zasshi; 1991 May; 28(3):371-6. PubMed ID: 1654468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium, parathyroid hormone and phospholipid turnover of human red blood cells.
    Brautbar N; Chakraborty J; Coats J; Massry SG
    Miner Electrolyte Metab; 1985; 11(2):111-6. PubMed ID: 2985943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.
    Akmal M; Telfer N; Ansari AN; Massry SG
    J Clin Invest; 1985 Oct; 76(4):1695-8. PubMed ID: 4056047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone and anaemia--an erythrocyte osmotic fragility study in primary and secondary hyperparathyroidism.
    Foulks CJ; Mills GM; Wright LF
    Postgrad Med J; 1989 Mar; 65(761):136-9. PubMed ID: 2813231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of relation between serum parathyroid hormone levels and erythrocyte osmotic fragility in pediatric patients on peritoneal dialysis.
    Koşan C; Sever L; Arisoy N
    Ren Fail; 2004 Nov; 26(6):683-7. PubMed ID: 15600260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
    Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
    Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aging on renal response to parathyroid hormone in vitro.
    Itoh K; Hara T
    Biochem Int; 1992 Aug; 27(4):633-9. PubMed ID: 1358071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in calcium-handling of erythrocytes in spontaneously hypertensive rats. Calcium-induced changes in the osmotic fragility of erythrocytes in hypertension.
    Tsuda K; Minatogawa Y; Tsuda S; Shima H; Nishio I; Kido R; Masuyama Y
    Jpn Heart J; 1987 Nov; 28(6):923-31. PubMed ID: 3444041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell calcium homeostasis in patients with end-stage renal disease.
    Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
    J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence of cellular events in pancreatic islets leading to impaired insulin secretion in chronic kidney disease.
    Massry SG
    J Ren Nutr; 2011 Jan; 21(1):92-9. PubMed ID: 21195928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Ca pump and Ca ATPase in the erythrocytes of patients with hypertension: disorders detected in cytoskeletal membranes and in solubilized Ca ATPase].
    Pokudin NI; Orlov SN; Postnov IuV
    Kardiologiia; 1986 Mar; 26(3):94-9. PubMed ID: 2423739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of calcium in parathyroid hormone actions in rabbit renal proximal tubules.
    Yanagawa N; Jo OD
    Am J Physiol; 1986 May; 250(5 Pt 2):F942-8. PubMed ID: 3706546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.